Format

Send to

Choose Destination
Cancer Sci. 2016 Mar;107(3):369-71. doi: 10.1111/cas.12889.

Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report.

Author information

1
Tokyo Women's Medical University, Tokyo, Japan.
2
St. Luke's International Hospital, Tokyo, Japan.
3
Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
4
Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
5
National Center for Global Health and Medicine, Tokyo, Japan.
6
Jikei University School of Medicine, Tokyo, Japan.
7
Department of General Internal Medicine, Dentistry and Oncologic Emergencies, National Cancer Center Hospital, Tokyo, Japan.
8
Department of Biochemistry, Kitasato University School of Medicine, Sagamihara, Japan.
9
National Cancer Center Research Center for Cancer Prevention and Screening, Tokyo, Japan.
10
Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
11
Department of Public Health and Occupational Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
12
Center for Antibody and Vaccine Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
13
National Cancer Center Research Institute, Tokyo, Japan.

Abstract

The Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer published its first report in July 2013 on the epidemiological assessment of the associations of diabetes with cancer risk/prognosis, the common risk factors for diabetes and cancer, and cancer risk associated with diabetes treatment. The Joint Committee continued its work to assess the role of glycemic control in the development of cancer in patients with diabetes. This review shows that high-quality evidence examining the association between glycemic control and cancer risk is lacking.

KEYWORDS:

Cancer; HbA1c; diabetes; glucose control; observational studies; randomized controlled trials

PMID:
27027540
PMCID:
PMC4814249
DOI:
10.1111/cas.12889
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center